211 related articles for article (PubMed ID: 35563446)
21. Enzymatically quiescent heparanase augments T cell interactions with VCAM-1 and extracellular matrix components under versatile dynamic contexts.
Sotnikov I; Hershkoviz R; Grabovsky V; Ilan N; Cahalon L; Vlodavsky I; Alon R; Lider O
J Immunol; 2004 May; 172(9):5185-93. PubMed ID: 15100255
[TBL] [Abstract][Full Text] [Related]
22. Substrate specificity of heparanases from human hepatoma and platelets.
Pikas DS; Li JP; Vlodavsky I; Lindahl U
J Biol Chem; 1998 Jul; 273(30):18770-7. PubMed ID: 9668050
[TBL] [Abstract][Full Text] [Related]
23. P-selectin- and heparanase-dependent antimetastatic activity of non-anticoagulant heparins.
Hostettler N; Naggi A; Torri G; Ishai-Michaeli R; Casu B; Vlodavsky I; Borsig L
FASEB J; 2007 Nov; 21(13):3562-72. PubMed ID: 17557930
[TBL] [Abstract][Full Text] [Related]
24. Heparanase and a synthetic peptide of heparan sulfate-interacting protein recognize common sites on cell surface and extracellular matrix heparan sulfate.
Marchetti D; Liu S; Spohn WC; Carson DD
J Biol Chem; 1997 Jun; 272(25):15891-7. PubMed ID: 9188488
[TBL] [Abstract][Full Text] [Related]
25. Heparanase uptake is mediated by cell membrane heparan sulfate proteoglycans.
Gingis-Velitski S; Zetser A; Kaplan V; Ben-Zaken O; Cohen E; Levy-Adam F; Bashenko Y; Flugelman MY; Vlodavsky I; Ilan N
J Biol Chem; 2004 Oct; 279(42):44084-92. PubMed ID: 15292202
[TBL] [Abstract][Full Text] [Related]
26. [Role of eukaryotic initiation factor-4E (eIF-4E) in regulation of expression of NF-kappaB and its subsequent influence on transcription and activity of heparanase in human colon adenocarcinoma cell line].
Yang YJ; Zhang YL; Wang JD; Lai ZS; Wang QY; Cui HH
Ai Zheng; 2003 Oct; 22(10):1023-9. PubMed ID: 14558943
[TBL] [Abstract][Full Text] [Related]
27. Heparanase, heparin and the coagulation system in cancer progression.
Vlodavsky I; Ilan N; Nadir Y; Brenner B; Katz BZ; Naggi A; Torri G; Casu B; Sasisekharan R
Thromb Res; 2007; 120 Suppl 2():S112-20. PubMed ID: 18023704
[TBL] [Abstract][Full Text] [Related]
28. Soluble heparan sulfate fragments generated by heparanase trigger the release of pro-inflammatory cytokines through TLR-4.
Goodall KJ; Poon IK; Phipps S; Hulett MD
PLoS One; 2014; 9(10):e109596. PubMed ID: 25295599
[TBL] [Abstract][Full Text] [Related]
29. A functional heparan sulfate mimetic implicates both heparanase and heparan sulfate in tumor angiogenesis and invasion in a mouse model of multistage cancer.
Joyce JA; Freeman C; Meyer-Morse N; Parish CR; Hanahan D
Oncogene; 2005 Jun; 24(25):4037-51. PubMed ID: 15806157
[TBL] [Abstract][Full Text] [Related]
30. The relevance of glycosaminoglycan sulfates to Apo E induced lipid uptake by hepatocyte monolayers.
Oswald B; Shelburne F; Landis B; Linker A; Quarfordt S
Biochem Biophys Res Commun; 1986 Nov; 141(1):158-64. PubMed ID: 2948501
[TBL] [Abstract][Full Text] [Related]
31. Heparanase modulates heparinoids anticoagulant activities via non-enzymatic mechanisms.
Katz BZ; Muhl L; Zwang E; Ilan N; Herishanu Y; Deutsch V; Naparstek E; Vlodavsky I; Preissner KT
Thromb Haemost; 2007 Dec; 98(6):1193-9. PubMed ID: 18064313
[TBL] [Abstract][Full Text] [Related]
32. Testing of potential glycan-based heparanase inhibitors in a fluorescence activity assay using either bacterial heparinase II or human heparanase.
Schoenfeld AK; Vierfuß S; Lühn S; Alban S
J Pharm Biomed Anal; 2014 Jul; 95():130-8. PubMed ID: 24667567
[TBL] [Abstract][Full Text] [Related]
33. Histidine-rich glycoprotein binds heparanase and regulates its enzymatic activity and cell surface interactions.
Poon IK; Yee DY; Jones AL; Wood RJ; Davis DS; Freeman C; Parish CR; Hulett MD
Int J Biochem Cell Biol; 2010 Sep; 42(9):1507-16. PubMed ID: 20561914
[TBL] [Abstract][Full Text] [Related]
34. Assessment of Heparanase-Mediated Angiogenesis Using Microvascular Endothelial Cells: Identification of λ-Carrageenan Derivative as a Potent Anti Angiogenic Agent.
Poupard N; Badarou P; Fasani F; Groult H; Bridiau N; Sannier F; Bordenave-Juchereau S; Kieda C; Piot JM; Grillon C; Fruitier-Arnaudin I; Maugard T
Mar Drugs; 2017 May; 15(5):. PubMed ID: 28486399
[TBL] [Abstract][Full Text] [Related]
35. Thrombin enhances degradation of heparan sulfate in the extracellular matrix by tumor cell heparanase.
Benezra M; Vlodavsky I; Bar-Shavit R
Exp Cell Res; 1992 Jul; 201(1):208-15. PubMed ID: 1612123
[TBL] [Abstract][Full Text] [Related]
36. Heparanase modulation by Wingless/INT (Wnt).
Melo CM; Nader HB; Justo GZ; Pinhal MAS
Mol Biol Rep; 2021 Apr; 48(4):3117-3125. PubMed ID: 33891270
[TBL] [Abstract][Full Text] [Related]
37. Keratinocytes-associated chemokines and enzymatically quiescent heparanase induce the binding of resting CD4+ T cells.
Hershkoviz R; Marikovsky M; Gilat D; Lider O
J Invest Dermatol; 1996 Feb; 106(2):243-8. PubMed ID: 8601723
[TBL] [Abstract][Full Text] [Related]
38. The role of heparin, heparanase and heparan sulfates in hepcidin regulation.
Asperti M; Denardo A; Gryzik M; Arosio P; Poli M
Vitam Horm; 2019; 110():157-188. PubMed ID: 30798810
[TBL] [Abstract][Full Text] [Related]
39. Unraveling the specificity of heparanase utilizing synthetic substrates.
Peterson SB; Liu J
J Biol Chem; 2010 May; 285(19):14504-13. PubMed ID: 20181948
[TBL] [Abstract][Full Text] [Related]
40. Heparanase augments inflammatory chemokine production from colorectal carcinoma cell lines.
Tsunekawa N; Higashi N; Kogane Y; Waki M; Shida H; Nishimura Y; Adachi H; Nakajima M; Irimura T
Biochem Biophys Res Commun; 2016 Jan; 469(4):878-83. PubMed ID: 26713365
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
